Pricing Log in Create free account

LeonaBio, Inc. (LONA) vs Sangamo Therapeutics, Inc. (SGMOQ)

LeonaBio, Inc. and Sangamo Therapeutics, Inc. are both Biotechnology companies. LeonaBio, Inc. and Sangamo Therapeutics, Inc. are of similar size ($41.9M and $40.9M). LeonaBio, Inc. has the higher net margin (0.00% vs −356.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Sangamo Therapeutics, Inc. leads on 6 and LeonaBio, Inc. on 5.

Valuation

Metric LONA SGMOQ Biotechnology median
P/E n/m n/m 10.60
P/S n/m 1.24 9.40
P/B 3.12 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 1.24 9.02
Earnings yield (522.84%) (345.45%) (32.88%)
Free cash flow yield (59.08%) (211.06%) (23.13%)

Profitability

Metric LONA SGMOQ Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% (357.55%) 0.00%
Net margin 0.00% (356.89%) 0.00%
Free cash flow margin 0.00% (261.76%) 0.00%
Return on equity (431.39%) 1,755.72% (51.96%)
Return on assets (306.05%) (168.79%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LONA SGMOQ Biotechnology median
Revenue growth (TTM) — (45.80%) 6.76%
EPS growth (last fiscal year) 1.98% 10.20% 29.88%
Revenue growth, 5-year CAGR — (19.66%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LONA SGMOQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.01 0.70 4.97
Net debt to EBITDA 0.87 0.18 1.01

Dividend

Metric LONA SGMOQ Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric LONA SGMOQ Biotechnology median
Market cap 40.89m 41.89m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack